Quilimmune-P pneumococcal vaccine: Phase I trial

Aquila Biopharmaceuticals Inc. (AQLA), Worcester,

Read the full 56 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE